{"References": [{"title": "SGLT2 inhibitors and kidney protection: from mechanisms to clinical outcomes", "authors": "David Z. Cherney, Hiddo J. Lambers Heerspink", "journal": "Clinical Journal of the American Society of Nephrology", "year": "2020", "volumes": "15", "first page": "702", "last page": "712", "DOI": "10.2215/CJN.12391019"}, {"title": "Effects of canagliflozin on renal outcomes in type 2 diabetes and nephropathy", "authors": "Vlado Perkovic, Ken Mahaffey, Bruce Neal, Dick de Zeeuw, Hiddo J. Lambers Heerspink, David W. Johnson, Meg J. Jardine, John Chalmers, Mark Cooper, Bryan Williams, Jonathan Emberson, Richard Haynes, Louise A. Levin, David R. Matthews, Martin J. Landray", "journal": "New England Journal of Medicine", "year": "2019", "volumes": "380", "first page": "2295", "last page": "2306", "DOI": "10.1056/NEJMoa1811744"}, {"title": "Dapagliflozin in patients with chronic kidney disease", "authors": "Hiddo J. Lambers Heerspink, Vivekanand Jha, David Z. Cherney, Glenn M. Chertow, Christoph Wanner, John McMurray, Peter Rossing, Richard E. Gilbert, David Wheeler, Dick de Zeeuw, Bruce Neal, Vlado Perkovic", "journal": "New England Journal of Medicine", "year": "2020", "volumes": "383", "first page": "1436", "last page": "1446", "DOI": "10.1056/NEJMoa2024816"}, {"title": "SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors in patients with type 2 diabetes and renal outcomes: a meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors and risk of acute kidney injury: a systematic review and meta-analysis of randomized controlled trials", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "Diabetes Care", "year": "2018", "volumes": "41", "first page": "1801", "last page": "1808", "DOI": "10.2337/dc18-0280"}, {"title": "Renal outcomes with canagliflozin in patients with type 2 diabetes and chronic kidney disease: a meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors and cardiovascular and renal outcomes in type 2 diabetes: a meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors and renal outcomes: a systematic review and meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors and renal outcomes in patients with type 2 diabetes: a systematic review and meta-analysis", "authors": "Brendon Neuen, Meg J. Jardine, Vlado Perkovic, David W. Johnson, Bruce Neal, Hiddo J. Lambers Heerspink, Richard E. Gilbert, David R. Matthews, John Chalmers, Jonathan Emberson, Richard Haynes, Louise A. Levin, Martin J. Landray", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}]}